Lansoprazole enhances the antidiabetic effect of dapagliflozin in fortified diet‐fed streptozotocin‐treated diabetic rats
- 23 January 2020
- journal article
- research article
- Published by Wiley in Journal of Biochemical and Molecular Toxicology
- Vol. 34 (4) , e22451
Abstract
Dapagliflozin (DAPA) is used for treating type 2 diabetes, whereas lansoprazole (LPZ) is used as a traditional antiulcer drug. The present study investigated the possible antidiabetic effects of LPZ on fortified diet‐fed streptozotocin (FDF/STZ)‐induced insulin‐resistant diabetic rats. On the basis of the current results, it can be concluded that LPZ could be used as an add‐on drug along with the conventional treatment for T2D as it showed beneficial effects in the current experimental model of insulin resistance.Keywords
This publication has 89 references indexed in Scilit:
- Preventive Effect of Dipeptidyl Peptidase-4 Inhibitor on Atherosclerosis Is Mainly Attributable to Incretin's Actions in Nondiabetic and Diabetic Apolipoprotein E-Null MicePLOS ONE, 2013
- Metabolic Risk Susceptibility in Men Is Partially Related to Adiponectin/Leptin RatioJournal of Obesity, 2013
- Effects of Dapagliflozin on Body Weight, Total Fat Mass, and Regional Adipose Tissue Distribution in Patients with Type 2 Diabetes Mellitus with Inadequate Glycemic Control on MetforminThe Journal of Clinical Endocrinology & Metabolism, 2012
- More than insulinNature Biotechnology, 2011
- Activation of peroxisome proliferator-activated receptor-α enhances fatty acid oxidation in human adipocytesBiochemical and Biophysical Research Communications, 2011
- SGLT2 Deletion Improves Glucose Homeostasis and Preserves Pancreatic β-Cell FunctionDiabetes, 2011
- Treatment with a proton pump inhibitor improves glycaemic control in Psammomys obesus, a model of type 2 diabetesDiabetologia, 2010
- The Characterization of High‐Fat Diet and Multiple Low‐Dose Streptozotocin Induced Type 2 Diabetes Rat ModelJournal of Diabetes Research, 2008
- Mechanisms linking obesity to insulin resistance and type 2 diabetesNature, 2006
- Insulin resistance, lipid and fatty acid concentrations in 867 healthy EuropeansEuropean Journal of Clinical Investigation, 2000